文献速递心力衰竭与心肌病

英国射血分数保留的心力衰竭注册研究:依据与设计

Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry.
PubMed 文献 · Heart · 2024-02-12

英国射血分数保留的心力衰竭注册研究(UK HFpEF)是一项前瞻性数据赋能的队列与平台研究,旨在建立大规模、高度特征化的HFpEF患者队列及生物样本库。研究整合深度临床表型、影像、多组学与全国电子健康记录数据,以重新分类HFpEF亚组、揭示疾病机制并识别新生物通路与分子靶点,为亚组特异性诊断与靶向治疗及更高效的临床试验奠定基础。

要点

  • UK HFpEF注册研究旨在建立大规模、多模态数据整合的HFpEF队列与平台
  • 通过深度表型、影像、多组学与电子健康记录整合重新分类HFpEF亚组
  • 入组标准为心衰专家诊断HFpEF、已测利钠肽且左室射血分数>40%

核心结论

  • UK HFpEF将建立丰富的多模态数据资源,以识别疾病内型并开发更有效的诊断策略、精准风险分层和靶向治疗。

研究设计与样本

  • UK HFpEF是一项前瞻性数据赋能的队列与平台研究,将建立大规模、高度特征化的HFpEF患者队列及生物样本库。
  • 研究整合深度临床表型、影像、多组学及集中持有的全国电子健康记录数据。
  • 入组标准为心衰专家诊断HFpEF、已测利钠肽水平且左室射血分数>40%。
  • 射血分数40%至49%的患者限制为不超过队列的25%。
  • 试验注册号:NCT05441839。

关键数值与推荐

  • 入组要求心衰专家诊断HFpEF、已测利钠肽且左室射血分数>40%。
  • 射血分数40%至49%的患者不超过队列的25%。

临床怎么用

  • 该平台旨在聚焦预期靶向干预有效的亚组,通过预先知情同意促进快速入组并链接随访,以支持更有效、更高效的临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Heart failure with preserved ejection fraction (HFpEF) is a common heterogeneous syndrome that remains imprecisely defined and consequently has limited treatment options and poor outcomes. METHODS: The UK Heart Failure with Preserved Ejection Fraction Registry (UK HFpEF) is a prospective data-enabled cohort and platform study. The study will develop a large, highly characterised cohort of patients with HFpEF. A biobank will be established. Deep clinical phenotyping, imaging, multiomics and centrally held national electronic health record data will be integrated at scale, in order to reclassify HFpEF into distinct subgroups, improve understanding of disease mechanisms and identify new biological pathways and molecular targets. Together, these will form the basis for developing diagnostics and targeted therapeutics specific to subgroups. It will be a platform for more effective and efficient trials, focusing on subgroups in whom targeted interventions are expected to be effective, with consent in place to facilitate rapid recruitment, and linkage for follow-up. Patients with a diagnosis of HFpEF made by a heart failure specialist, who have had natriuretic peptide levels measured and a left ventricular ejection fraction >40% are eligible. Patients with an ejection fraction between 40% and 49% will be limited to no more than 25% of the cohort. CONCLUSIONS: UK HFpEF will develop a rich, multimodal data resource to enable the identification of disease endotypes and develop more effective diagnostic strategies, precise risk stratification and targeted therapeutics. TRIAL REGISTRATION NUMBER: NCT05441839.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry. Heart. 2024. PMID: 37827557. doi:10.1136/heartjnl-2023-323049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。